Movantik
Grünenthal Acquires US-Based Valinor Pharma for $250 Million
Grünenthal, Valinor Pharma, acquisition, Movantik, naloxegol, opioid-induced constipation, pain management, US market expansion, pharmaceutical industry
Grünenthal Expands US Presence with $250 Million Acquisition of Valinor Pharma and Movantik
Grünenthal, Valinor Pharma, Movantik, Acquisition, US Expansion, Pharmaceutical Industry